CN1056765C - 治疗慢性退缩型精神病的宁神药物组合物 - Google Patents
治疗慢性退缩型精神病的宁神药物组合物 Download PDFInfo
- Publication number
- CN1056765C CN1056765C CN95117422A CN95117422A CN1056765C CN 1056765 C CN1056765 C CN 1056765C CN 95117422 A CN95117422 A CN 95117422A CN 95117422 A CN95117422 A CN 95117422A CN 1056765 C CN1056765 C CN 1056765C
- Authority
- CN
- China
- Prior art keywords
- psychosis
- medicine
- ningshen
- radix
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000028017 Psychotic disease Diseases 0.000 title claims abstract description 26
- 230000001684 chronic effect Effects 0.000 title claims abstract description 15
- 239000000203 mixture Substances 0.000 title claims abstract description 6
- RGCVKNLCSQQDEP-UHFFFAOYSA-N Perphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 RGCVKNLCSQQDEP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960000762 perphenazine Drugs 0.000 claims abstract description 11
- BGRJTUBHPOOWDU-NSHDSACASA-N (S)-(-)-sulpiride Chemical compound CCN1CCC[C@H]1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-NSHDSACASA-N 0.000 claims abstract description 9
- 229960004940 sulpiride Drugs 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical group C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 claims description 8
- 229960001032 trihexyphenidyl Drugs 0.000 claims description 8
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 6
- 241000237636 Pheretima Species 0.000 claims description 6
- 241000736148 Styrax Species 0.000 claims description 6
- 239000004870 Styrax Substances 0.000 claims description 6
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 6
- 239000003814 drug Substances 0.000 abstract description 53
- 230000000694 effects Effects 0.000 abstract description 24
- 239000000126 substance Substances 0.000 abstract description 14
- 229940079593 drug Drugs 0.000 abstract description 12
- 231100000331 toxic Toxicity 0.000 abstract description 11
- 230000002588 toxic effect Effects 0.000 abstract description 11
- 230000007547 defect Effects 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 230000002085 persistent effect Effects 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 4
- 229960001076 chlorpromazine Drugs 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100001274 therapeutic index Toxicity 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 230000000561 anti-psychotic effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 206010050013 Abulia Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164439 Curcuma angustifolia Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000027776 Extrapyramidal disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 241000233948 Typha Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | N | 疗效总评(GI) | 副反应 | 疗效指数(EI) |
实验组 | 50 | 1.70±0.52 | 1.14±0.42 | 3.44±1.15 |
对照组 | 50 | 1.43±0.38 | 2.80±0.80 | 2.45±1.25 |
X2 | P>0.05 | P<0.01 | P<0.01 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95117422A CN1056765C (zh) | 1995-11-06 | 1995-11-06 | 治疗慢性退缩型精神病的宁神药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95117422A CN1056765C (zh) | 1995-11-06 | 1995-11-06 | 治疗慢性退缩型精神病的宁神药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1149476A CN1149476A (zh) | 1997-05-14 |
CN1056765C true CN1056765C (zh) | 2000-09-27 |
Family
ID=5081215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95117422A Expired - Fee Related CN1056765C (zh) | 1995-11-06 | 1995-11-06 | 治疗慢性退缩型精神病的宁神药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1056765C (zh) |
-
1995
- 1995-11-06 CN CN95117422A patent/CN1056765C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1149476A (zh) | 1997-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103784933B (zh) | 复发性口腔溃疡散 | |
CN1140279C (zh) | 一种治疗心脑血管疾病的药物 | |
CN101279034B (zh) | 一种内服和外用结合治疗糖尿病的组合中药及制备方法 | |
CN1056765C (zh) | 治疗慢性退缩型精神病的宁神药物组合物 | |
CN105125885B (zh) | 一种用于防治糖尿病的中药组合物及其制备方法 | |
CN1194724C (zh) | 治疗冠心病心绞痛的中药制剂及其制备方法 | |
CN1730090A (zh) | 一种治疗肝病的中药组合物及其制备方法 | |
CN102247515B (zh) | 治疗糖尿病肾病的中药复方制剂及其制备方法 | |
CN102225082A (zh) | 一种防治糖尿病及其并发症的药物和其制备方法 | |
CN1142786C (zh) | 一种治疗冠心病的药物 | |
CN1054523C (zh) | 一种治疗抑郁型精神病的宁神药物组合物 | |
CN1246020C (zh) | 一种用于酒精性脂肪肝病的药物组合物 | |
CN1463734A (zh) | 一种治疗糖尿病的中成药及其制备方法 | |
CN1052896C (zh) | 一种抗精神病的宁神药物组合物 | |
CN101322762B (zh) | 一种治疗糖尿病的药物组合物 | |
CN1219415A (zh) | 一种治疗"慢性退缩型"精神病的药物组合物 | |
CN103142928A (zh) | 骨筋口服液及其制备方法 | |
CN1054525C (zh) | 一种治疗“下消”型糖尿病的药物组合物 | |
CN1954841A (zh) | 治疗慢性咽炎的药物 | |
CN1853711A (zh) | 一种心脉康中药组合物及其制备方法 | |
CN105456404A (zh) | 制备加快烧烫伤创面愈合的药物组合物外用散剂的方法 | |
CN1219416A (zh) | 一种治疗“消极抑郁型”精神病的药物组合物 | |
CN103784794A (zh) | 一种降低血脂的药物组合物及其应用 | |
CN101757410A (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN102451248B (zh) | 一种中药组合物在制备治疗糖尿病神经病变药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Co-applicant after: Lin Yulin Co-applicant before: Zong Yuhua |
|
CB03 | Change of inventor or designer information |
Inventor after: Lin Yulin Inventor after: Chen Jinhua Inventor after: Lin Zuxian Inventor after: Fu Chunfu Inventor before: Chen Jinhua Inventor before: Lin Zuxian Inventor before: Fu Chunfu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN JINHUA; LIN ZUXIAN; FU CHUNFU TO: LIN YULIN; CHEN JINHUA; LIN ZUXIAN;FU CHUNFU |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |